Xiaofen Li

Person

Mountain View, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
MCL-1 inhibitors
- Patent number 12,162,844
- Issue date Dec 10, 2024
- Gilead Sciences, Inc.
- Hang Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MCL-1 inhibitors
- Patent number 11,643,400
- Issue date May 9, 2023
- Gilead Sciences, Inc.
- Hang Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic heterocyclic compounds
- Patent number 11,229,638
- Issue date Jan 25, 2022
- Gilead Sciences, Inc.
- Mark J. Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic heterocyclic compounds
- Patent number 11,186,579
- Issue date Nov 30, 2021
- Gilead Sciences, Inc.
- Mark J. Bartlett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic heterocyclic compounds
- Patent number 11,098,027
- Issue date Aug 24, 2021
- Gilead Sciences, Inc.
- Mark J. Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic heterocyclic compounds
- Patent number 11,040,033
- Issue date Jun 22, 2021
- Gilead Sciences, Inc.
- Mark J. Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MCL-1 inhibitors
- Patent number 10,988,451
- Issue date Apr 27, 2021
- Gilead Sciences, Inc.
- Hang Chu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MCL-1 inhibitors
- Patent number 10,703,733
- Issue date Jul 7, 2020
- Gilead Sciences, Inc.
- Hang Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as CaM kinase inhibitors
- Patent number 10,100,058
- Issue date Oct 16, 2018
- Gilead Sciences, Inc.
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,695,192
- Issue date Jul 4, 2017
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,682,998
- Issue date Jun 20, 2017
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,676,760
- Issue date Jun 13, 2017
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,598,435
- Issue date Mar 21, 2017
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,403,782
- Issue date Aug 2, 2016
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,371,329
- Issue date Jun 21, 2016
- Gilead Sciences, Inc.
- Britton Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,193,694
- Issue date Nov 24, 2015
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 9,115,096
- Issue date Aug 25, 2015
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,962,610
- Issue date Feb 24, 2015
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,952,034
- Issue date Feb 10, 2015
- Gilead Sciences, Inc.
- Britton Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,754,103
- Issue date Jun 17, 2014
- Gilead Sciences, Inc.
- Britton Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,697,863
- Issue date Apr 15, 2014
- Gilead Sciences, Inc.
- Elfatih Elzein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,586,732
- Issue date Nov 19, 2013
- Gilead Sciences, Inc.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,389,500
- Issue date Mar 5, 2013
- Gilead Sciences, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
A2B adenosine receptor antagonists
- Patent number 8,324,224
- Issue date Dec 4, 2012
- Gilead Sciences, Inc.
- Rao Kalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ALDH-2 inhibitors in the treatment of addiction
- Patent number 8,158,810
- Issue date Apr 17, 2012
- Gilead Sciences, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
A2B adenosine receptor antagonists
- Patent number 7,795,269
- Issue date Sep 14, 2010
- Gilead Palo Alto, Inc.
- Rao Kalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A2B adenosine receptor antagonists
- Patent number 7,741,331
- Issue date Jun 22, 2010
- Gilead Palo Alto, Inc.
- Rao Kalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Partial and full agonists of A1 adenosine receptors
- Patent number 7,696,181
- Issue date Apr 13, 2010
- CV Therapeutics, Inc.
- Prabha Ibrahim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A2B adenosine receptor antagonists
- Patent number 7,521,554
- Issue date Apr 21, 2009
- CV Therapeutics, Inc.
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
A1 adenosine receptor agonists
- Patent number 7,514,417
- Issue date Apr 7, 2009
- CV Therapeutics, Inc.
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MACROCYCLIC COMPOUNDS AND METHODS OF USE
- Publication number 20240294551
- Publication date Sep 5, 2024
- Amgen Inc.
- Ryan Paul Wurz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MCL-1 INHIBITORS
- Publication number 20230312490
- Publication date Oct 5, 2023
- GILEAD SCIENCES, INC.
- Hang Chu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SMARCA2-VHL DEGRADERS
- Publication number 20230091042
- Publication date Mar 23, 2023
- Amgen Inc.
- Abhisek BANERJEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MCL-1 INHIBITORS
- Publication number 20220340535
- Publication date Oct 27, 2022
- GILEAD SCIENCES, INC.
- Hang Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MCL-1 INHIBITORS
- Publication number 20200331870
- Publication date Oct 22, 2020
- GILEAD SCIENCES, INC.
- Hang Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC HETEROCYCLIC COMPOUNDS
- Publication number 20200316035
- Publication date Oct 8, 2020
- GILEAD SCIENCES, INC.
- Mark J. Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC HETEROCYCLIC COMPOUNDS
- Publication number 20200031834
- Publication date Jan 30, 2020
- GILEAD SCIENCES, INC.
- Mark J. Bartlett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC HETEROCYCLIC COMPOUNDS
- Publication number 20200031801
- Publication date Jan 30, 2020
- GILEAD SCIENCES, INC.
- Mark J. Bartlett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MCL-1 INHIBITORS
- Publication number 20190352271
- Publication date Nov 21, 2019
- GILEAD SCIENCES, INC.
- Hang Chu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic heterocyclic compounds
- Publication number 20190192504
- Publication date Jun 27, 2019
- GILEAD SCIENCES, INC.
- Mark J. Bartlett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS CAM KINASE INHIBITORS
- Publication number 20180148457
- Publication date May 31, 2018
- GILEAD SCIENCES, INC.
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20160362421
- Publication date Dec 15, 2016
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20160347744
- Publication date Dec 1, 2016
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20160096846
- Publication date Apr 7, 2016
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20150329558
- Publication date Nov 19, 2015
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20150239904
- Publication date Aug 27, 2015
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20140303158
- Publication date Oct 9, 2014
- GILEAD SCIENCES, INC.
- Britton Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20140135317
- Publication date May 15, 2014
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20130184255
- Publication date Jul 18, 2013
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2B ADENOSINE RECEPTOR ANTAGONISTS
- Publication number 20130123280
- Publication date May 16, 2013
- GILEAD SCIENCES, INC.
- Rao V. Kalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20130012492
- Publication date Jan 10, 2013
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20130005706
- Publication date Jan 3, 2013
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20120289493
- Publication date Nov 15, 2012
- GILEAD SCIENCES, INC.
- Britton Kenneth Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
A2B ADENOSINE RECEPTOR ANTAGONISTS
- Publication number 20110257127
- Publication date Oct 20, 2011
- GILEAD SCIENCES, INC.
- Rao Kalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A2B ADENOSINE RECEPTOR ANTAGONISTS
- Publication number 20110130362
- Publication date Jun 2, 2011
- GILEAD SCIENCES, INC.
- Rao Kalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20110021521
- Publication date Jan 27, 2011
- Gilead Palo Alto, Inc.
- Britton Corkey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
A2B Adenosine Receptor Antagonists
- Publication number 20100222300
- Publication date Sep 2, 2010
- Gilead Palo Alto, Inc.
- Rao Kalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20100113449
- Publication date May 6, 2010
- Gilead Palo Alto, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION
- Publication number 20090209533
- Publication date Aug 20, 2009
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
A1 ADENOSINE RECEPTOR AGONISTS
- Publication number 20090156544
- Publication date Jun 18, 2009
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

MCL-1 inhibitors

MCL-1 inhibitors

Therapeutic heterocyclic compounds

Therapeutic heterocyclic compounds

Therapeutic heterocyclic compounds

Therapeutic heterocyclic compounds

MCL-1 inhibitors

MCL-1 inhibitors

Fused heterocyclic compounds as CaM kinase inhibitors

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

A2B adenosine receptor antagonists

ALDH-2 inhibitors in the treatment of addiction

A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

Partial and full agonists of A1 adenosine receptors

A2B adenosine receptor antagonists

A1 adenosine receptor agonists

Patents Applicationslast 30 patents

MACROCYCLIC COMPOUNDS AND METHODS OF USE

MCL-1 INHIBITORS

SMARCA2-VHL DEGRADERS

MCL-1 INHIBITORS

MCL-1 INHIBITORS

THERAPEUTIC HETEROCYCLIC COMPOUNDS

THERAPEUTIC HETEROCYCLIC COMPOUNDS

THERAPEUTIC HETEROCYCLIC COMPOUNDS

MCL-1 INHIBITORS

Therapeutic heterocyclic compounds

FUSED HETEROCYCLIC COMPOUNDS AS CAM KINASE INHIBITORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

A2B ADENOSINE RECEPTOR ANTAGONISTS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

A2B ADENOSINE RECEPTOR ANTAGONISTS

A2B ADENOSINE RECEPTOR ANTAGONISTS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

A2B Adenosine Receptor Antagonists

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION

A1 ADENOSINE RECEPTOR AGONISTS